HCA Healthcare, Inc. (NYSE:HCA) Stock Holdings Lessened by LVW Advisors LLC

LVW Advisors LLC lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 34.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,892 shares of the company’s stock after selling 1,492 shares during the period. LVW Advisors LLC’s holdings in HCA Healthcare were worth $868,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the stock. Terra Nova Asset Management LLC increased its holdings in shares of HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after buying an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its stake in HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after purchasing an additional 29 shares during the period. Waldron Private Wealth LLC raised its stake in HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after purchasing an additional 29 shares during the period. Brookstone Capital Management raised its stake in HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after purchasing an additional 30 shares during the period. Finally, UMB Bank n.a. raised its stake in HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares during the period. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 0.4 %

Shares of HCA opened at $310.60 on Monday. The company has a 50-day simple moving average of $316.69 and a 200-day simple moving average of $353.01. The firm has a market capitalization of $78.67 billion, a P/E ratio of 13.95, a P/E/G ratio of 1.03 and a beta of 1.64. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a 52 week low of $278.50 and a 52 week high of $417.14.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. KeyCorp cut their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. Oppenheimer boosted their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Finally, Barclays lowered their price target on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.